EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta‐analysis

Ana Treviño-Nakoura, Daniel Sepúlveda-Crespo, José M Bellon, Helena Codina, Rafael Amigot-Sánchez, Marta Quero-Delgado, Pablo Ryan, Isidoro Martínez, Salvador Resino iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70018 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Ana Treviño-Nakoura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain. Hauptthemen laut MEDLINE: Dried Blood Spot Testing, Hepacivirus, Hepatitis C, Mass Screening. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Gilead Science, CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea-NextGen….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dried blood spot (DBS) sampling is increasingly used for hepatitis C virus (HCV) screening. HCVcAg testing offers a faster and more streamlined approach to diagnosing HCV infection. We conducted a systematic review and meta‐analysis to assess the diagnostic performance of the Abbott ARCHITECT HCV Ag assay for screening active HCV infection using DBS samples. Eight studies ( n = 1229) were selected among all published studies available up to October 4, 2024, in different databases with a search strategy registered (PROSPERO: CRD42022363975). The gold standard method was the HCV PCR test. Data were analyzed using the MIDAS module in STATA with a random effects model. Combined diagnostic accuracy measures were as follows: sensitivity 85%, specificity 100%, positive likelihood ratio (PLR) 233.1, negative likelihood ratio (NLR) 0.15, and summary receiver operating characteristic (SROC) 0.99. Likelihood ratios and Fagan's nomogram suggested that the HCVcAg assay with DBS samples can confirm or rule out active HCV infection with over 92% accuracy in high‐prevalence settings (≥5%). However, in low‐prevalence settings (≤1%), a confirmatory test must be required for positive results. The ability of the test to identify people without HCV infection was high regardless of HCV prevalence, with an error rate of less than 3%. This meta‐analysis is subject to limitations, particularly due to the number of included studies and significant heterogeneity among them. HCV screening using the Abbott ARCHITECT HCV Ag assay with DBS samples showed excellent diagnostic performance, but its external validity may be limited when HCV prevalence is low (≤1%).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dried Blood Spot TestingHepacivirusHepatitis CMass ScreeningSensitivity and SpecificityHumansHepatitis C AntigensROC CurveViral Core Proteins

Stichwörter der Autor:innen

HCV core antigendiagnostic performancedried blood spothepatitis Cscreening

Substanzen

Hepatitis C AntigensViral Core Proteins

Autor:innen und Institutionen

  • Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
  • Instituto Mixto de Investigación Escuela Nacional de Sanidad-Universidad Nacional de Educación a Distancia (IMIENS-UNED), Madrid, Spain.
  • Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Servicio de Medicina Interna, Hospital Universitario Infanta Leonor, Madrid, Spain.

ORCID-Profile: Salvador Resino

Förderung

  • Instituto de Salud Carlos III
  • Gilead Science
  • CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea-NextGen…

Zitieren

APA

Treviño-Nakoura, A., Sepúlveda-Crespo, D., Bellon, J. M., Codina, H., Amigot-Sánchez, R., Quero-Delgado, M., Ryan, P., Martínez, I., & Resino, S. (2024). Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta‐analysis. Journal of Medical Virology. https://doi.org/10.1002/jmv.70018

Vancouver

Treviño-Nakoura A, Sepúlveda-Crespo D, Bellon JM, Codina H, Amigot-Sánchez R, Quero-Delgado M, et al. Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta‐analysis. Journal of Medical Virology. 2024. doi:10.1002/jmv.70018

BibTeX
@article{TrevioNakoura2024,
  author = {Treviño-Nakoura, Ana and Sepúlveda-Crespo, Daniel and Bellon, José M and Codina, Helena and Amigot-Sánchez, Rafael and Quero-Delgado, Marta and Ryan, Pablo and Martínez, Isidoro and Resino, Salvador},
  title = {Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta‐analysis},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70018}
}
Kostenlos starten →